Table 1.
Phenotype 1 | Phenotype 2 | Rg | Rg_SE | P-Value |
---|---|---|---|---|
Coffee consumption | Alzheimer's disease | −0.0033 | 0.0991 | 0.9732 |
Amyotrophic lateral sclerosis | −0.0514 | 0.1294 | 0.6914 | |
Neuroticism* | −0.1533 | 0.0387 | 7.27E-05 | |
Major depression disorder* | −0.1469 | 0.0447 | 0.0010 | |
Insomnia* | −0.1523 | 0.0451 | 0.0007 | |
Attention deficit and hyperactivity disorder | −0.0579 | 0.0586 | 0.3228 | |
Bipolar disorder | 0.0255 | 0.0444 | 0.5657 | |
Lifetime cannabis use* | 0.4814 | 0.0544 | 8.40E-19 | |
AUDIT_T* | 0.3926 | 0.0568 | 4.63E-13 | |
AUDIT_C* | 0.3981 | 0.0606 | 5.26E-11 | |
AUDIT_P* | 0.2769 | 0.0637 | 1.36E-05 | |
Anorexia nervosa | −0.0020 | 0.0637 | 0.9744 | |
Schizophrenia | 0.1002 | 0.0397 | 0.0117 |
Rg, genetic correlation estimate; SE, standard error; AUDIT_T, Alcohol use disorder identification test total score; AUDIT_C, alcohol consumption component of alcohol use disorder identification test item 1–3 scores; AUDIT_P, dependence and hazardous-use component of alcohol use disorder identification test item 4–10 scores.
*Correlations that were significant after Bonferroni correction (P <0.05/13 traits = 0.0038).